📩 info@dengyuemed.com
🔗https://dengyuepharma.com
#Entinostat #EntinostatTablets #Jingzhuda
#CáncerDeMama #CáncerDeMamaMetastásico
#HRpositivo #HER2negativo
#InhibidorHDAC #TerapiaDirigida
📩 info@dengyuemed.com
🔗https://dengyuepharma.com
#Entinostat #EntinostatTablets #Jingzhuda
#CáncerDeMama #CáncerDeMamaMetastásico
#HRpositivo #HER2negativo
#InhibidorHDAC #TerapiaDirigida
Potential therapeutic strategies (at least in silico):
- HDAC inhibitors (e.g. Entinostat, Vorinostat) — particularly interesting due to their epigenetic mechanisms
3/4
Potential therapeutic strategies (at least in silico):
- HDAC inhibitors (e.g. Entinostat, Vorinostat) — particularly interesting due to their epigenetic mechanisms
3/4
Therapieansätze (zumindest in silico)
- HDAC-Hemmer (z.B. Entinostat, Vorinostat; interessant v. a. weil epigenetischer Ansatz)
- Östrogen-Antagonisten (Fulvestrant)
➡️ Evtl.
3/4
Therapieansätze (zumindest in silico)
- HDAC-Hemmer (z.B. Entinostat, Vorinostat; interessant v. a. weil epigenetischer Ansatz)
- Östrogen-Antagonisten (Fulvestrant)
➡️ Evtl.
3/4
⌚️: 9 a.m. - 12 p.m. CT
📍: Hall A
⌚️: 9 a.m. - 12 p.m. CT
📍: Hall A
A novel nontoxic combination of ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma
🚨 New dataset alert! 🚨
A novel nontoxic combination of ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma
🚨 New dataset alert! 🚨
doi.org/10.3389/fimm...
doi.org/10.3389/fimm...